eISSN: 1644-4124
ISSN: 1426-3912
Central European Journal of Immunology
Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
1/2014
vol. 39
 
Share:
Send email
Share:
abstract:

Multiple gene mutations in patients with type 2 autoimmune pancreatitis and its clinical features

Feng Dong
,
Qing-quan Chen
,
Ze-hao Zhuang
,
Qing-liang He
,
Feng-qing Wang
,
Qi-cai Liu
,
He-kun Liu
,
Yu Wang

(Centr Eur J Immunol 2014; 39 (1): 77-82
DOI: https://doi.org/10.5114/ceji.2014.42129
Online publish date: 2014/04/22
View full text Get citation
 
PlumX metrics:
Background: It is now clear that there are two histological types (type 1 and type 2) of autoimmune pancreatitis (AIP). The histological substance of type 1 AIP is known as lymphoplasmacytic sclerosing pancreatitis (LPSP) or traditional AIP, and type 2 AIP is characterized by distinct histology called idiopathic duct centric pancreatitis (IDCP). Serum IgG4 increase is considered as a marker for type 1 AIP. Far less is known about type 2 and it lacks predicting markers, so it easily leads to missed diagnosis and misdiagnosis.

The aim of this study was to describe multi-gene mutations in patients with type 2 AIP and its clinical features.

Material and methods: Three unrelated patients with type 2 AIP, 10 cases with type 1 AIP, 15 cases with other chronic pancreatitis and 120 healthy individuals were studied. The mutations and polymorphisms of 6 genes involved in chronic pancreatitis or pancreatic cancer — PRSS1, SPINK1, CFTR, MEN1, PKHD1, and mitochondrial DNA – were sequenced. Information of clinical data was collected by personal interview using a structured questionnaire.

Results: Novel mutations were found in the genes encoding for MEN1 (p.546 Ala > The) and PKHD1 (c. 233586 A>G and c. 316713 C>T) from patients with type 2 AIP. What is more, the serum TCR (T cell receptor) level is relatively higher in patients with type 2 AIP than in patients with type 1 AIP and other chronic pancreatitis or normal controls. Weight loss was the major manifestation and no patients had extrapancreatic involvement in type 2 AIP.

Conclusions: Type 2 AIP may occur with multi-gene mutations. For screening purposes, it is more reasonable to evaluate TCR levels in serum.
keywords:

autoimmune pancreatitis, type 2, gene mutations, serum TCR
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.